Please login to the form below

Not currently logged in
Email:
Password:

BIND Biosciences

This page shows the latest BIND Biosciences news and features for those working in and with pharma, biotech and healthcare.

Amgen signs $180m nanotechnology cancer deal

Amgen signs $180m nanotechnology cancer deal

Amgen signs $180m nanotechnology cancer deal. Will combine BIND Biosciences' tissue-targeting technology with a molecularly-targeted drug. ... Amgen has teamed up with nanotechnology specialist BIND Biosciences to develop a new version of one of its

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Use of biomarkers in marketing

    Mark Assenti is a Senior Associate Consultant at Blue Latitude. Mark began his career in the biosciences field, studying genetics at Cardiff University.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics